Cardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role?

BACKGROUND: Metabolic syndrome and related metabolic disturbances represent a state of low-grade inflammation, which accelerates insulin resistance, type 2 diabetes (T2D) and cardiovascular disease (CVD) progression. Among antidiabetic medications, sodium glucose co-transporter (SGLT) 2 inhibitors a...

Descripción completa

Detalles Bibliográficos
Autores principales: Elrakaybi, Asmaa, Laubner, Katharina, Zhou, Qian, Hug, Martin J., Seufert, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352970/
https://www.ncbi.nlm.nih.gov/pubmed/35863639
http://dx.doi.org/10.1016/j.molmet.2022.101549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352970/
https://www.ncbi.nlm.nih.gov/pubmed/35863639
http://dx.doi.org/10.1016/j.molmet.2022.101549

Ejemplares similares